rss Posted October 24, 2013 Report Share Posted October 24, 2013 [Off-label indications for topical tacrolimus]. Hautarzt. 2013 Oct;64(10):752-6 Authors: Hengge UR Abstract The topical calcineurin antagonist tacrolimus plays an important role in the treatment of different forms of eczema because of its favorable risk profile. In addition, different off-label indications have been clinically tested where tacrolimus ointment has achieved clinical improvement. This article discusses off-label treatment of vitiligo, seborrheic dermatitis, steroid rosacea, perioral dermatitis, rosacea and lichen sclerosus. PMID: 24150824 [PubMed - in process] http://www.ncbi.nlm.nih.gov/pubmed/24150824?dopt=Abstract = URL to article Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now